Identification and Molecular Characterization of A Gene Encoding A Protective Leishmania amazonensis Trp-Asp (WD) Protein

Infection and Immunity

Volumn 72, Issue 4, 2004, Pages 2194-2202

  Campbell, Kimberly ^a   Popov, Vsevolod ^a   Soong, Lynn ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CD4 ANTIGEN; COMPLEMENTARY DNA; DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; MESSENGER RNA; PROTEIN; TRYPTOPHAN; UNCLASSIFIED DRUG; WD PROTEIN;

AMASTIGOTE; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA LIBRARY; FEMALE; FLAGELLUM; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; IMMUNOELECTRON MICROSCOPY; LEISHMANIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SKIN LEISHMANIASIS; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ASPARTIC ACID; CD4-POSITIVE T-LYMPHOCYTES; CRICETINAE; FEMALE; HUMANS; IMMUNIZATION; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; MESOCRICETUS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, DNA; TRYPTOPHAN;

EID: 1842536061     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.4.2194-2202.2004     Document Type: Article

References (41)

1. Aebischer, T., M. Wolfram, S. I. Patzer, T. Ilg, M. Wiese, and P. Overath. 2000. Subunit vaccination of mice against New World cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants. Infect. Immun. 68:1328-1336.
2. Berberof, M., L. Vanhamme, and E. Pays. 1995. Trypanosoma brucei: a preferential splicing at the inverted polyaderylation site of the VSG mRNA provides further evidence for coupling between trans-splicing and polyadenylation. Exp. Parasitol. 80:563-567.
3. Beyrodt, C. G., A. R. Pinto, E. Freymuller, and C. L. Barbieri. 1997. Characterization of an antigen from Leishmania amazonensis amastigotes able to elicit protective responses in a murine model. Infect. Immun. 65:2052-2059.
4. Burnette, W. N. 1981. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitro-cellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112:195-203.
5. Burns, J. M., Jr., W. G. Shreffier, D. R. Benson, H. W. Ghalib, R. Badaro, and S. G. Reed. 1993. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc. Natl. Acad. Sci. USA 90:775-779.
6. Campbell, K., H. Diao, J. Ji, and L. Soong. 2003. DNA immunization with the gene encoding P4 nuclease of Leishmania amazonensis protects mice against cutaneous leishmaniasis. Infect. Immun. 71:6270-6278.
7. Campos-Neto, A., L. Soong, J. L. Cordova, D. Sant'Angelo, Y. A. Skeiky, N. H. Ruddle, S. G. Reed, C. Janeway, Jr., and D. McMahon-Pratt. 1995. Cloning and expression of a Leishmania donovani gene instructed by a peptide isolated from major histocompatibility complex class II molecules of infected macrophages. J. Exp. Med. 182:1423-1433.
8. Campos-Neto, A., J. R. Webb, K. Greeson, R. N. Coler, Y. A. Skeiky, and S. G. Reed. 2002. Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c mice. Infect. Immun. 70:2828-2836.
9. Courret, N., E. Prina, E. Mougneau, E. M. Saraiva, D. L. Sacks, N. Glaichenhaus, and J. C. Antoine. 1999. Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites. Eur. J. Immunol. 29:762-773.
10. Fong, H. K., J. B. Hurley, R. S. Hopkins, R. Miake-Lye, M. S. Johnson, R. F. Doolittle, and M. I. Simon. 1986. Repetitive segmental structure of the transducin beta subunit: homology with the CDC4 gene and identification of related mRNAs. Proc. Natl. Acad. Sci. USA 83:2162-2166.
11. Gopfert, U., N. Goehring, C. Klein, and T. Ilg. 1999. Proteophosphoglycans of Leishmania mexicana. Molecular cloning and characterization of the Leishmania mexicana ppg2 gene encoding the proteophosphoglycans aPPG and pPPG2 that are secreted by amastigotes and promastigotes. Biochem. J. 344:787-795.
12. Gurunathan, S., C. Prussin, D. L. Sacks, and R. A. Seder. 1998. Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection. Nat. Med. 4:1409-1415.
13. Gurunathan, S., C. Y. Wu, B. L. Freidag, and R. A. Seder. 2000. DNA vaccines: a key for inducing long-term cellular immunity. Curr. Opin. Immunol. 12:442-447.
14. Hodgkinson, V. H., L. Soong, S. M. Duboise, and D. McMahon-Pratt. 1996. Leishmania amazonensis: cultivation and characterization of axenic amastigote-like organisms. Exp. Parasitol. 83:94-105.
15. Ji, J., J. Sun, H. Qi, and L. Soong. 2002. Analysis of T helper cell responses during infection with Leishmania amazonensis. Am. J. Trop. Med. Hyg. 66:338-345.
16. Khaskhely, N. M., M. Maruno, A. Takamiyagi, H. Uezato, K. M. Kasem, et al. 2001. Pre-exposure with low-dose UVA suppresses lesion development and enhances Th1 responses in BALB/c mice infected with Leishmania (Leishmania) amazonensis. J. Derm. Sci. 26:217-232.
17. Kozak, M. 1986. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283-292.
18. Lambright, D. G., J. Sondek, A. Bohm, N. P. Skiba, H. E. Hamm, and P. B. Sigler. 1996. The 2.0 A crystal structure of a heterotrimeric G protein. Nature 379:311-319.
19. Locksley, R. M., and J. A. Louis. 1992. Immunology of leishmaniasis. Curr. Opin. Immunol. 4:413-418.
20. Mattner, F., J. Magram, J. Ferrante, P. Launois, K. Di Padova, R. Behin, M. K. Gately, J. A. Louis, and G. Alber. 1996. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26:1553-1559.
21. McConville, M. J., K. A. Mullin, S. C. Ilgoutz, and R. D. Teasdale. 2002. Secretory pathway of trypanosomatid parasites. Microbiol. Mol. Biol. Rev. 66:122-154.
22. Melby, P. C., G. B. Ogden, H. A. Flores, W. Zhao, C. Geldmacher, N. M. Biediger, S. K. Ahuja, J. Uranga, and M. Melendez. 2000. Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library. Infect. Immun. 68:5595-5602.
23. Mougneau, E., F. Altare, A. E. Wakil, S. Zheng, T. Coppola, Z. E. Wang, R. Waldmann, R. M. Locksley, and N. Glaichenhaus. 1995. Expression cloning of a protective Leishmania antigen. Science 268:563-566.
24. Mullin, K. A., B. J. Foth, S. C. Ilgoutz, J. M. Callaghan, J. L. Zawadzki, G. I. McFadden, and M. J. McConville. 2001. Regulated degradation of an endoplasmic reticulum membrane protein in a tubular lysosome in Leishmania mexicana. Mol. Biol. Cell. 12:2364-2377.
25. Neer, E. J., C. J. Schmidt, R. Nambudripad, and T. F. Smith. 1994. The ancient regulatory-protein family of WD-repeat proteins. Nature 371:297-300.
26. Pan American Health Organization. 1994. Leishmaniasis in the Americas. Epidemiol. Bull. 15:8-13.
27. Popov, V. L., X. Yu, and D. H. Walker. 2000. The 120 kDa outer membrane protein of Ehrlichia chaffeensis: preferential expression on dense-core cells and gene expression in Escherichia coli associated with attachment and entry. Microb. Pathog. 28:71-80.
28. Requena, J. M., L. Quijada, M. Soto, and C. Alonso. 2003. Conserved nucleotides surrounding the trans-splicing acceptor site and the translation initiation codon in Leishmania genes. Exp. Parasitol. 103:78-81.
29. Sacerdoti-Sierra, N., and C. L. Jaffe. 1997. Release of ecto-protein kinases by the protozoan parasite Leishmania major. J. Biol. Chem. 272:30760-30765.
30. Siman-Tov, M. M., A. C. Ivens, and C. L. Jaffe. 2002. Molecular cloning and characterization of two new isoforms of the protein kinase A catalytic subunit from the human parasite Leishmania. Gene 288:65-75.
31. Smith, T. F., C. Gaitatzes, K. Saxena, and E. J. Neer. 1999. The WD repeat: a common architecture for diverse functions. Trends Biochem. Sci. 24:181-185.
32. + T cells in pathogenesis associated with Leishmania amazonensis infection. J. Immunol. 158:5374-5383.
33. Soong, L., S. M. Duboise, P. Kima, and D. McMahon-Pratt. 1995. Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis. Infect. Immun. 63:3559-3566.
34. Sprague, E. R., M. J. Redd, A. D. Johnson, and C. Wolberger. 2000. Structure of the C-terminal domain of Tup1, a corepressor of transcription in yeast. EMBO J. 19:3016-3027.
35. Ulmer, J. B., J. J. Donnelly, and M. A. Liu. 1996. DNA vaccines: promising a new approach to inducing protective immunity. ASM News 62:476.
36. Vannier-Santos, M. A., A. Martiny, J. R. Meyer-Fernandes, and W. de Souza. 1995. Leishmanial protein kinase C modulates host cell infection via secreted acid phosphatase. Eur. J. Cell Biol. 67:112-119.
37. Venter, J. C., M. D. Adams, E. W. Myers, P. W. Li, R. J. Mural, et al. 2001. The sequence of the human genome. Science 291:1304-1351.
38. Wall, M. A., D. E. Coleman, E. Lee, J. A. Iniguez-Lluhi, B. A. Posner, A. G. Gilman, and S. R. Sprang. 1995. The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. Cell 83:1047-1058.
39. Webb, J. R., A. Campos-Neto, P. J. Ovendale, T. I. Martin, E. J. Stromberg, R. Badaro, and S. G. Reed. 1998. Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family. Infect. Immun. 66:3279-3289.
40. Webb, J. R., D. Kaufmann, A. Campos-Neto, and S. G. Reed. 1996. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis. J. Immunol. 157:5034-5041.
41. Yu, L., C. Gaitatzes, E. Neer, and T. F. Smith. 2000. Thirty-plus functional families from a single motif. Protein Sci. 9:2470-2476.